Discontinuation of anti‑programmed cell death protein 1 immune checkpoint inhibition after complete remission in head and neck squamous cell carcinoma: A case report and literature review

Programmed cell death protein 1 (PD-1) inhibition plays a central role in the current treatment of recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC). Some patients achieve a durable response, and even complete remission (CR) is possible, though it occurs rarely. In cases of d...

Descripción completa

Detalles Bibliográficos
Autores principales: Stöth, Manuel, Meyer, Till, Gehrke, Thomas, Hagen, Rudolf, Scheich, Matthias, Hackenberg, Stephan, Scherzad, Agmal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561138/
https://www.ncbi.nlm.nih.gov/pubmed/37818135
http://dx.doi.org/10.3892/ol.2023.14076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561138/
https://www.ncbi.nlm.nih.gov/pubmed/37818135
http://dx.doi.org/10.3892/ol.2023.14076

Ejemplares similares